The Shareholders Foundation announces that an investor in OTCMKTS:FSPM filed a lawsuit over alleged violations of Federal Securities Laws by Fusion Pharm Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fusion Pharm Inc (OTCMKTS:FSPM) have certain options and for certain investors are short and strict deadlines running. Deadline: April 18, 2017. OTCMKTS:FSPM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
According to the complaint the plaintiff alleges on behalf of purchasers of FusionPharm Inc (OTCMKTS:FSPM) common shares between March 31, 2012 and September 16, 2016, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 31, 2012 and September 16, 2016, the defendants caused the Company to issue materially misleading representations and/or omit material information regarding the Company’s purported revenues and sales of its PharmPods during the Class Period
On September 16, 2016, the Securities and Exchange Commission (“SEC”) announced fraud charges against Fusion Pharm Inc and its CEO, Scott M. Dittman, among others, for allegedly misleading investors by recording and trumpeting revenues for purported sales of PharmPods by round-tripping money from illegal stock sales by hidden affiliates.
Those who purchased OTCMKTS:FSPM shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com